Methods and systems for depositing active ingredients on substrates

US11547675B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11547675-B2
Application numberUS-201615751771-A
CountryUS
Kind codeB2
Filing dateAug 9, 2016
Priority dateAug 10, 2015
Publication dateJan 10, 2023
Grant dateJan 10, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods for delivering active ingredients, such as pharmaceutically active ingredients, to substrates are described herein. The active ingredients are delivered as fluids to a fluid-dispensing device for the creation of one or more drops for deposition onto substrates such as for the creation of microdoses. The invention further includes microdoses made by such processes.

First claim

Opening claim text (preview).

We claim: 1. An active ingredient delivery system comprising: a. a fluid reservoir for receiving a fluid therein; b. a fluid-delivery apparatus comprising a pump, a fluid-dispensing device comprising a first end and a second end, and a heated air tube extending between a housing of the pump and the fluid dispensing device, wherein the first end of the fluid-dispensing device is in fluid communication with the fluid reservoir via a fluid transfer tube positioned inside the heated air tube, and the pump is positioned to transfer the fluid from the reservoir, through the pump, and to and through the fluid-dispensing device; c. a real-time drop-imaging and measurement device; and d. a substrate holder positioned below the second end of the fluid dispensing device, the substrate holder comprising a heating element, a cooler, and a stage configured to position a substrate thereon to receive the fluid flowing through the second end of the fluid-dispensing device; wherein the fluid reservoir contains a fluid suspension comprising an active ingredient and the fluid-dispensing device comprises a nozzle. 2. The system of claim 1 , wherein the fluid suspension comprises one or more of an excipient and a colloid. 3. The system of claim 1 , wherein the active ingredient is a pharmaceutically active ingredient. 4. The system of claim 1 , wherein at least one of the reservoir, the nozzle, and/or the pump is/are under temperature control. 5. The system of claim 1 , wherein the pump is a positive displacement pump and further comprises a controller for adjusting pump parameters. 6. The system of claim 1 , wherein at least a portion of the real-time drop-imaging and measurement device is positioned between the second end of the fluid dispensing device and the substrate holder and configured to image the fluid suspension emerging from the second end of the fluid dispensing device as one or more drops and the real-time drop-imaging and measurement device is further configured to measure a volume of the one or more drops. 7. The system of claim 1 , wherein the fluid dispensing device is a nozzle, the system further comprising a detector positioned below and transverse the second end of the nozzle, the detector comprising a photosensor and two fiber optic cables mounted on a housing attached to a nozzle assembly, wherein the detector device is configured to send a signal to activate the real-time drop imaging and measurement device when one or more drops of the fluid passes in front of a light beam passing between ends of the two fiber optic cables. 8. The system of claim 7 , further comprising a backlight, wherein the backlight is configured so that when one or more drops of the fluid are imaged, light from the backlight is in a field of view of a camera of the real-time drop imaging and measurement device, the camera directed at the one or more drops of the fluid, and wherein said light is perpendicular to the light beam from the two fiber optic cables. 9. The system of claim 1 , further comprising an analytical instrument configured to analyze active ingredients of the substrate, and wherein the analytical instrument is selected from one or more of the group consisting of a Raman spectrometer, an infrared spectrometer, an x-ray powder diffractometer, a differential scanning calorimeter, a thermal gravimetric analyzer, a mass spectrometer, a gravimetric instrument, a dissolution apparatus, a particle size measurement instrument, a gas displacement pycnometer, a tapped density tester, and a chromatography instrument. 10. A method for delivering an active ingredient to a substrate, comprising the steps of: a. preparing a fluid suspension comprising an excipient and pharmaceutically active ingredient; b. transporting the fluid suspension, using a pump, through the fluid transfer tube, through the pump, and into the nozzle, wherein the fluid transfer tube is positioned inside a heated air tube extending between a housing of the pump and the nozzle; c. ejecting the prepared fluid suspension through a nozzle onto a substrate positioned below the nozzle on a substrate holder comprising a heating element, a cooler, and a stage, wherein the nozzle creates one or more drops of the fluid suspension; and d. measuring the volume of the one or more drops of the fluid suspension using a real-time drop-imaging and measurement device. 11. The method of claim 10 , wherein: the excipient comprises a polymer, and the fluid suspension is heated within a fluid reservoir to a temperature greater than a melting temperature of the polymer, the fluid reservoir in fluid communication with the nozzle via the fluid transfer tube. 12. The method of claim 10 , wherein a diameter of the nozzle is adjusted so that the one or more drops have a volume between about one microliter and about 35 microliters per drop. 13. The method of claim 10 , wherein a volume of the one or more drops is measured after the one or more drops exit the nozzle. 14. The method of claim 10 , further comprising the step of analyzing the pharmaceutically active ingredient on the substrate. 15. A method for preparing a microdose of an active pharmaceutical ingredient comprising: a. preparing a fluid suspension comprising an excipient and one or more active pharmaceutical ingredients; b. using a pump, transporting the prepared fluid through the pump and a fluid transfer tube positioned inside a heated air tube, the fluid transfer tube and heated air tube extending between a housing of the pump and a nozzle, and ejecting the prepared fluid through the nozzle onto a substrate holder positioned below the nozzle, wherein the nozzle creates one or more drops of the fluid and wherein the substrate holder comprises a stage, a substrate, a heating element and a cooler; c. measuring the volume of the one or more drops; and d. processing the one or more drops to provide a microdose of the one or more active pharmaceutical ingredients. 16. The method of claim 15 , wherein the excipient comprises at least one of a polymer, lipid, or surfactant, and a positive displacement pump is used to eject the fluid suspension. 17. The method of claim 15 , wherein the substrate is selected from the group consisting of a dermal patch, a sublingual product, a buccal product, an injectable, a syringe, a tablet, a film strip, a capsule, and a vial. 18. The method of claim 15 , wherein the processing comprises reducing a temperature of the substrate so that the fluid suspension hardens.

Assignees

Inventors

Classifications

  • the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil · CPC title

  • A61K9/7007Primary

    Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence) · CPC title

  • Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title

  • the outlet side being of particular interest · CPC title

  • Feed or outlet control devices · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11547675B2 cover?
Systems and methods for delivering active ingredients, such as pharmaceutically active ingredients, to substrates are described herein. The active ingredients are delivered as fluids to a fluid-dispensing device for the creation of one or more drops for deposition onto substrates such as for the creation of microdoses. The invention further includes microdoses made by such processes.
Who is the assignee on this patent?
Purdue Research Foundation
What technology area does this patent fall under?
Primary CPC classification A61K9/7007. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).